Adjuvant capecitabine: safe and tolerable option for adjuvant treatment in patients with resected pancreas and ampullary adenocarcinoma

C Rigby, A Lamarca, Mairead Mcnamara, D O'Reilly, A Siriwardena, R Hubner, J Valle

    Research output: Contribution to conferencePoster

    Fingerprint

    Dive into the research topics of 'Adjuvant capecitabine: safe and tolerable option for adjuvant treatment in patients with resected pancreas and ampullary adenocarcinoma'. Together they form a unique fingerprint.

    Medicine and Dentistry

    Pharmacology, Toxicology and Pharmaceutical Science

    Biochemistry, Genetics and Molecular Biology

    Immunology and Microbiology